Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dan
    wiki wiki
    • Jul 2008
    • 194

    #31
    Originally posted by ECO View Post
    I'm definitely out of my league in this discussion, but if anyone needs hosting for some of these sample datasets, let me know!
    Can we make a wiki to store all the datasets and results? A nice table would be soo cool! Also, I think people contributing data and analysis to a wiki page is more 'cite-able' than forum posts, although this is clearly an effective mechanism for community discussion. A wiki page to summarize this thread could be a good 'citation'. I tried to find a suitable spot on Wikipedia, but they don't even have an article for next-generation sequencing yet, never mind short read aligners to cope with the data.

    I'd like to start benchmarking the de-novo aligners (where accuracy is much harder to pin down). This will become more and more of an issue as all the genome sequencing projects move over to next-gen technology.


    BTW, anyone seen this:

    I’ll be attending the coveted Marco Island meeting early next month (February 4-8), where I’ll present a poster on my evaluations of short read aligners for next-gen sequencing data



    Looks relevant to the topic of this thread.
    Last edited by dan; 01-22-2009, 06:09 AM. Reason: added a note about looking for a suitable page on Wikipedia
    Homepage: Dan Bolser
    MetaBase the database of biological databases.

    Comment

    • der_eiskern
      Member
      • Jul 2009
      • 46

      #32
      Originally posted by regyre View Post
      Hi lh3,

      Thanks for the original benchmarking! I'm actually looking for such a benchmarking including the latest tools, like ZOOM!, bowtie, R Biostings pairwiseAlignment(), etc. Has anybody heard of that?

      Cheers,

      N.
      I second this. I'd be interested in a comparison of erroneous mappings with the dominant WGS alignment-to-ref tools.

      Comment

      • joa_ds
        Member
        • Dec 2008
        • 52

        #33
        Hi there, i am under some pressure to deliver results from a solexa run. They did a run, and all i had to do was give them a list of variants.

        Problem is, i ran bowtie, give them the list. They verify with Sanger sequencing, and the results are different. So i used MAQ then. Results different than BowTie results (but also different than the 'reality' obtained with Sanger).

        So I have a lot of questionmarks... If results vary depending on the mapping software, well, my neighboor's genome has not changed since i pressed the MAQ button, so that is a problem.

        You guys still think using Eland will give me some 'strength' in explaining i did the best possible mapping i could do?

        Problem is that they have multiple genotypes mixed and are looking for QTL's, so a 40% or 60% variant, in the 'normal world' is just a heterozygous variant, in QTL world, it is a big difference...

        Comment

        • Nomijill
          Member
          • Sep 2009
          • 25

          #34
          This is great thank you.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-06-2026, 07:41 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Working...